Parálisis Periódica Hipocalémica Tirotóxica Aporte del laboratorio en un nuevo desafío diagnostico
Main Article Content
Abstract
La Parálisis Periódica Tirotóxica Hipocalémica es una patología de muy baja frecuencia en Argentina, no obstante, es muy importante tenerla en cuenta como urgencia, ya que puede ser fatal de no hacerse en forma oportuna el diagnostico y tratamiento correcto. El objetivo de esta investigación es destacar el aumento de incidencia de una enfermedad en las salas de guardia de nuestro país, potencialmente fatal y a la vez fácilmente reversible con el tratamiento adecuado y oportuno, a fin de tenerse en cuenta en las sospechas diagnósticas de emergencia y el aporte que puede hacer el bioquímico, desde un servicio de urgencia, para ayudar al diagnostico en forma rápida y certera.
Summary:
Hypokalemic Thyrotoxic Periodic Paralysis is a disease of very low frequency in Argentina, however, it is very important to take it into account as an emergency, because if it is not timely diagnosed and correctly treatment it can be fatal. The objective of this research is to distinguish the disease´s increased incidence in the emergency rooms of our country, which is potentially fatal, and at the same time it is easily reversible with proper and timely treatment, to be considered in the emergency diagnostic suspicion and the contribution that the biochemist can make from an emergency service to subserve the diagnosis quickly and accurately.
Article Details
The magazine does not retain the reproduction rights (copyright) so the authors can republish their works with the sole mention of the original publication source.
References
[1] Lin SH, Lin YF, Halpering ML. Hypokalemia and paralysis. QJM 2001; 94: 133-9.
[1] Maurya PK, Kalita J, Misra UK. Spectrum of hypokalaemic periodic paralysis in a tertiary care centre in India. Postgrad Med J 2010; 86: 692-695.
[1] Phakdeekitcharoen B, Ruangraksa C, Radinahamed P. Hypokalaemia and paralysis in the Thai population. Nephrol Dial Transplant 2004; 19: 2013-2018.
[1] Pothiwala P, Levine SN. Analytic review: thyrotoxic periodic paralysis: a review. J Intensive Care
Med 2010; 25: 71-77.
[1] Kung AW. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol
Metab 2006; 91: 2490-2495.
[1] McFadzean, A. J., and Yeung R. "Periodic paralysis complicating thyrotoxicosis in Chinese." British medical journal 1.5538 (1967): 451.
[1] Días DA, Silva MR, Chiamolera MI, Kasamatsu TS, Cerutti JM, Maciel RM. Paralisia Periódica Hipocalémica Tirotóxica, Uma Urgencia Endócrina: Revisão do Quadro Clínico e Genético de 25 Pacientes. Arq Bras Endocrinol Metab 2004; 48: 196-215.
[1] Kung, Annie WC. "Thyrotoxic periodic paralysis: a diagnostic challenge." The Journal of Clinical Endocrinology & Metabolism 91.7 (2006): 2490-2495.
[1] Aparicio MM, Ballarino MC, Bertini K, Mallea Gil MS, Ridruejo MC. Tirotoxicosis y parálisis
periódica. Alta frecuencia en nuestro medio. Rev Argent Endocrinol Metab Sup 44 (2007).
[1] Lin YF, Wu CC, Pei D, Chu SJ, Lin SH. Diagnostic Thyrotoxic Periodic Paralysis in the ED. Am J
Emerg Med 2003; 21: 339-42
[1] Stedwell RE, Allen KM, Binder LS. Hypokalemic paralyses: A review of the etiologies,
pathophysiology, presentation and therapy. Am J Emerg Med 1992; 10: 143-6.
[1] Magsino e, RyanJ. Thyrotoxic periodic paralysis. South Med J 2000; 93:996-1003
[1] Neisser Morales-Victorino, Luis Guevara-Arnal, Paloma Almeda-Valdés. Parálisis
tirotóxica. Informe de un caso y revisión de la literatura. Revista de Investigación Médica Sur 2008;
2: 81-85.
[1] Ober, K. Thyrotoxic periodic paralysis in t he United States. Report of 7 cases and review of the
literatura. Medicine 1992; 71:109-1 18
[1] Ryan DP, Dias Da Silva MR, Soong TW, et al. Mutations in Potassium Channel Kir2. 6 Cause
Susceptibility to Thyrotoxic Periodic Paralysis. Cell 2010; 140:88-98.
[1] Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R. In vivo and in vitro sodium pump
activity in subjects with thyrotoxic periodic paralysis. Br Med J 1991; 303: 1096-9.
[1] Shih-Hua Lin* and Chou-Long Huang†. Mechanism of Thyrotoxic Periodic Paralysis. J Am Soc
Nephrol 2012; 23: 985–988.
[1] Harrison, AP and Clausen, T. "Thyroid hormone-induced upregulation of Na+ channels and Na+-K+ pumps:
implications for contractility." American Journal of Physiology-Regulatory, Integrative and Comparative
Physiology 274.3 (1998): R864-R867.
[1] Soonthornpun S, Setasuban W, Thamprasit A. Insulin resistance in subjects with a history of
thyrotoxic periodic paralysis. Clin Endocrinol (Oxf) 2009; 70:794-7.
[1] Kung AW. Thyrotoxic periodic paralysis: A diagnostic Challenge. J Clin Endocrinol Metab 2006;
91: 2490-2495
[1] Goldberger ZD. An Electrocardiogram Triad in Thyrotoxic Hypokalemic Periodic Paralysis.
Circulation 2007; 115: e179-e180.
[1] Lin SH, Chu P, Cheng CJ et al. Early diagnosis of thyrotoxic periodic paralysis: Spot urine calcium
to phosphate ratio. Crit. Care Med 2006; 34: 2984-2989
[1] Lien, Y.H.H. A new diagnostic test for an old diagnostic challenge: Thyrotoxic periodic paralysis.
Crit Care Med 2006; Critical care medicine 34.12 (2006): 3053-3054.
[1] Lin SH, Chiu JS, Hsu CW, et al. A simple and rapid approach to hypokalemic paralysis. Am J
Emerg Med 2003; 21:487–491.
[1] Lin SH, Lin YF, Chen DT, Chu P, Hsu CW, Halperin ML. Laboratory Tests to Determine the Cause
of Hypokalemia and Paralysis. Arch Intern Med 2004; 164: 1561-6.
[1] Lu KC, Hsu YJ, Chiu JS, Hsu YD, Lin SH 2004 Effects of potassium supplementation on the
recovery of thyrotoxic periodic paralysis. The American journal of emergency medicine 22.7 (2004): 544-547.
[1] Birkhahn RH, Gaeta TJ, Melniker L. Thyrotoxic periodic paralysis and intravenous propranolol in
the emergency setting. J Emerg Med 2000; 18: 199-202.
[1] Yu TS, Tseng CF, Chuang YY, Yeung LK, Lu KC. Potassium chloride supplementation alone may
not improve hypokalemia in thyrotoxic hypokalemic periodic paralysis. J Emerg Med 2007;
32:263-5.
[1] Chen DY, Schneider PF, Zhang XS, He ZM, Chen TH. Fatality after cardiac arrest in thyrotoxic
periodic paralysis due to profound hypokalemia resulting from intravenous glucose administration
and inadequate potassium replacement. Thyroid 2012; 22: 969-972.